BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15889254)

  • 1. CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype.
    Casado JG; Soto R; DelaRosa O; Peralbo E; del Carmen Muñoz-Villanueva M; Rioja L; Peña J; Solana R; Tarazona R
    Cancer Immunol Immunother; 2005 Dec; 54(12):1162-71. PubMed ID: 15889254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands.
    Solana R; Casado JG; Delgado E; DelaRosa O; Marín J; Durán E; Pawelec G; Tarazona R
    Cancer Immunol Immunother; 2007 Jan; 56(1):101-9. PubMed ID: 16485126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword?
    Tarazona R; Casado JG; Soto R; DelaRosa O; Peralbo E; Rioja L; Peña J; Solana R
    Cancer Immunol Immunother; 2004 Oct; 53(10):911-24. PubMed ID: 15127235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
    Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
    Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
    Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 T cells expressing killer Ig-like receptors and NKG2A are present in cord blood and express a more naïve phenotype than their counterparts in adult blood.
    Warren HS; Rana PM; Rieger DT; Hewitt KA; Dahlstrom JE; Kent AL
    J Leukoc Biol; 2006 Jun; 79(6):1252-9. PubMed ID: 16574769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells.
    Ugolini S; Arpin C; Anfossi N; Walzer T; Cambiaggi A; Förster R; Lipp M; Toes RE; Melief CJ; Marvel J; Vivier E
    Nat Immunol; 2001 May; 2(5):430-5. PubMed ID: 11323697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined low dose cyclosporine and prednisone down-regulate natural killer cell-like effector functions of CD8brightCD56+ T cells in patients with active Behçet uveitis.
    Ahn JK; Park YG; Park SW; Yoon KC; Yu HG; Chung H
    Ocul Immunol Inflamm; 2006 Oct; 14(5):267-75. PubMed ID: 17056460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
    Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
    Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
    Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.
    Warrington KJ; Takemura S; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2001 Jan; 44(1):13-20. PubMed ID: 11212151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
    Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
    Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
    Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes.
    Anumanthan A; Bensussan A; Boumsell L; Christ AD; Blumberg RS; Voss SD; Patel AT; Robertson MJ; Nadler LM; Freeman GJ
    J Immunol; 1998 Sep; 161(6):2780-90. PubMed ID: 9743336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
    Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
    Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T large granular lymphocytes in asymptomatic patients.
    Casado LF; Granados E; Algara P; Navarro F; Martinez-Frejo MC; López-Botet M
    Haematologica; 2001 May; 86(5):457-63. PubMed ID: 11410407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
    Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
    Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
    Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.